Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads

References

• Lopes CM, Sousa Lobo JM, Pinto JF, Costa P. Compressed mini-tablets as a biphasic delivery system. Int J Pharm 2006;323(1–2):93–100.
   PubMed Web of Science ®Google Scholar
• Abbaspour MR, Sadeghi F, Afrasiabi Garekani H. Design and study of ibuprofen disintegrating sustained release tablets comprising coated pellets. Eur J Pharm Biopharm 2008;68(3):747–759.
   PubMedGoogle Scholar
• Beckert TE, Lehmann K, Schmidt PC. Compression of enteric-coated pellets to disintegrating tablets. Int J Pharm 1996:143(1):13–23.
   Google Scholar
• El-Gazayerly ON, Rakkanka V, Ayres JW. Novel chewable sustained-release tablet containing verapamil hydrochloride. Pharm Dev Tech 2004;9(2):181–188.
   PubMed Web of Science ®Google Scholar
• Bodmeier R. Tableting of coated pellets. Eur J Pharm Biopharm 1997;43(1):1–8.
   Google Scholar
• Celik M, Maganti L. Formulation and compaction of microspheres. Drug Dev Ind Pharm 1994;20(20):3151–3173.
   Google Scholar
• Pongjanyakul T, Priprem A, Chitropas P, Puttipipatkhachorn S. Effect of polysulfonate resins and direct compression fillers on multiple-unit sustained-release dextromethorphan resinate tablets. AAPS Pharm Sci Tech 2005;6(2): article 28.
   Google Scholar
• Borgquist P, Nevsten P, Nilsson B, Wallenberg LR, Axelsson A. Simulation of the release from a multiparticulate system validated by single pellet and dose release experiments. J Control Release 2004;97(3):453–465.
   PubMedGoogle Scholar
• Qiu Y, Zhang G. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000. p 472.
   Google Scholar
• Homdrum EM, Likar R, Nell G. Xefo® rapid: A novel effective tool for pain treatment. Eur Surg 2006;38(5):342–352.
   Google Scholar
• Staunstrup H, Ovesen J, Larsen UT, Elbaek K, Larsen U, Kroner K. Efficacy and tolerability of lornoxicam versus tramadol in postoperative pain. J Clin Pharmacol 1999;39:834–841.
   PubMed Web of Science ®Google Scholar
• Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam. Clin Pharmacokinet 1998;34(6):421–428.
   PubMedGoogle Scholar
• Hamza YE, Aburahma MH. Innovation of novel sustained release compression-coated tablets for lornoxicam: Formulation and in vitro investigations. Drug Dev Ind Pharm 2010;36(3):337–349.
   PubMedGoogle Scholar
• Hamza YE, Aburahma MH. Design and in vitro evaluation of novel sustained-release matrix tablets for lornoxicam based on the combination of hydrophilic matrix formers and basic pH-modifiers. Pharm Dev Tech 2010;15(2):139–153.
   PubMedGoogle Scholar
• Anal AK, Bhopatkar D, Tokura S, Tamura H, Stevens WF. Chitosan-alginate multilayer beads for gastric passage and controlled intestinal release of protein. Drug Dev Ind Pharm 2003;29(6):713–724.
   PubMedGoogle Scholar
• Anal AK, Stevens WF. Chitosan-alginate multilayer beads for controlled release of ampicillin. Int J Pharm 2005;290(1–2):45–54.
   PubMedGoogle Scholar
• Kim WT, Chung H, Shin IS, Yam KL, Chung D. Characterization of calcium alginate and chitosan-treated calcium alginate gel beads entrapping allyl isothiocyanate. Carbohydrate Polymers 2008;71(4):566–573.
   Google Scholar
• Sevgi F, Kaynarsoy B, Ozyazici M, Pekcetin C, Ozyurt D. A comparative histological study of alginate beads as a promising controlled release delivery for mefenamic acid. Pharm Dev Tech 2008;13(5):387–392.
   PubMedGoogle Scholar
• Sevgi F, Yurdasiper A, Kaynarsoy B, Turunç E, Güneri T, Yalçın A. Studies on mefenamic acid microparticles: Formulation, in vitro release, and in situ studies in rats. AAPS Pharm Sci Tech 2009;10(1):104–112.
   PubMedGoogle Scholar
• Yegin BA, Moulari B, Durlu-Kandilci NT, Korkusuz P, Pellequer Y, Lamprecht A. Sulindac loaded alginate beads for a mucoprotective and controlled drug release. J Microencapsul 2007;24(4):371–382.
   PubMedGoogle Scholar
• Arica B, Caliş S, Atilla P, Durlu NT, Cakar N, Kaş HS, Hincal AA. In vitro and in vivo studies of ibuprofen-loaded biodegradable alginate beads. J Microencapsul 2005;22(2):153–165.
   PubMed Web of Science ®Google Scholar
• Lee B-J, Min G-H. Oral controlled release of melatonin using polymer-reinforced and coated alginate beads. Int J Pharm 1996;144(1):37–46.
   Google Scholar
• Lee B-J, Min G-H. Preparation and release characteristics of polymer-reinforced and coated alginate beads. Arch Pharm Res 1995;18(3):183–188.
   Google Scholar
• Sriamornsak P, Thirawong N, Putkhachorn S. Morphology and buoyancy of oil entrapped calcium pectinate gel beads. AAPS J 2004;6(3): article 24.
   Google Scholar
• El-Kamel AH, Al-Gohary OMN, Hosny EA. Alginate-diltiazem hydrochloride beads: optimization of formulation factors, in vitro and in vivo availability. J Microencapsul 2003;20(2):211–225.
   PubMed Web of Science ®Google Scholar
• Manjanna KM, Shivakumar B, Pramod Kumar TM. Formulation of oral sustained release aceclofenac sodium microbeads. Int J PharmTech Research 2009;1(3):940–952.
   Google Scholar
• Liew CV, Chan LW, Ching AL, Heng PW. Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm 2006;309(1–2):25–37.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996;20(6):64–74.
   Google Scholar
• The British Pharmacopoeia. British Pharmacopoeia Commission. London: HMSO; 2007 (electronic version).
   Google Scholar
• Albarghouthi M, Abu Fara D, Saleem M, El-Taher T, Matalka K, Badwan A. Immobilization of antibodies on alginate-chitosan beads. Int J Pharm 2000;206(1–2):23–34.
   PubMedGoogle Scholar
• Hari PR, Chandy T, Sharma CP. Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J Microencapsul 1996;13(3):319–329.
   PubMedGoogle Scholar
• Pasparakis G, Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int J Pharm 2006;323(1–2):34–42.
   PubMed Web of Science ®Google Scholar
• Fathy M, Safwat, SM, El-Shanawany SM, Shawky Tous S, Otagiri M. Preparation and evaluation of beads made of different calcium alginate compositions for oral sustained release of tiaramide. Pharm Dev Technol 1998;3(3):355–364.
   PubMedGoogle Scholar
• Xing L, Dawei C, Liping X, Rongqing Z. Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads entrapped entrapped liposome. J Control Release 2003;93(3):293–300.
   PubMedGoogle Scholar
• Bajpai SK, Sharma S. Investigation of swelling/degradation behavior of alginate beads crosslinked with Ca2+ and Ba2+ ions. React Funct Polym 2004;59(2):129–140.
   Google Scholar
• Dainty AL, Goulding KH, Robinson PK, Sinpkins I, Trevan MD. Stability of alginate-immobilized algal cells. Biotechnol Bioeng 1986;28(2):210–216.
   PubMedGoogle Scholar
• Liu LS, Liu SQ, Steven YN, Froix M, Ohno T, Heller J. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release 1997;43(1):65–74.
   Google Scholar
• González-Rodríguez ML, Holgado MA, Sánchez-Lafuente C, Rabasco AM, Fini A. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm 2002;232(1–2):225–234.
   PubMedGoogle Scholar
• Ribeiro L, Ferreira DC, Veiga FJ. In vitro controlled release of vinpocetine-cyclodextrin-tartaric acid multicomponent complexes from HPMC swellable tablets. J Control Release 2005;103(2):325–339.
   PubMed Web of Science ®Google Scholar
• Davis SS, Hardy JG, Taylor MJ, Whalley DR, Wilson CG. A comparative study of the gastrointestinal transit of a pellet and tablet formulation. Int J Pharm 1984;21(2):167–177.
   Web of Science ®Google Scholar
• Zheng CH, Gao JQ, Zhang YP, Liang WQ. A protein delivery system: Biodegradable alginate-chitosan-poly(lactic-co-glycolic acid) composite microspheres. Biochem Biophys Res Commun 2004;323(4):1321–1327.
   PubMedGoogle Scholar
• Takahashi T, Takayama K, Machida Y, Nagai T. Characteristics of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm 1990;61(1–2):35–41.
   Google Scholar
• Smidsrod O, Skjak-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol 1990;8(3):71–78.
   PubMedGoogle Scholar
• Abbaspour MR, Sadeghi F, Afrasiabi Garekani H. Design and study of ibuprofen disintegrating sustained release tablets comprising coated pellets. Eur J Pharm Biopharm 2008;68(3):747–759.
   PubMedGoogle Scholar
• Beckert TE, Lehmann K, Schmidt PC. Compression of enteric-coated pellets to disintegrating tablets. Int J Pharm 1996;143(1):13–23.
   Google Scholar
• Torrado JJ, Augsburger LL. Effect of different excipients on the tableting of coated particles. Int J Pharm 1994;106(2):149–155.
   Google Scholar
• Zhang Y, La Y, Chakrabarti S. Physical properties and compact analysis of commonly used direct compression binders. AAPS Pharm Sci Tech 2003;4(4): article 62.
   Google Scholar
• Felton LA. Film coating of oral solid dosage forms. In: Encyclopedia of pharmaceutical technology. 3rd ed. USA: Informa Healthcare; 2006:1736–1737.
   Google Scholar
• Schwartz JB, Nguyen NH, Schnaare RL. Compaction studies on beads: Compression and consolidation parameters. Drug Dev Ind Pharm 1994;20(20):3105–3129.
   Google Scholar
• Gupta VK, Beckert TE, Assmus MW, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm 2001;213(1–2):83–91.
   PubMedGoogle Scholar
• Lopes CM, Sousa Lobo JM, Costa P, Pinto JF. Directly compressed mini matrix tablets containing ibuprofen: Preparation and evaluation of sustained release. Drug Dev Ind Pharm 2006;32(1):95–106.
   PubMedGoogle Scholar